Occupational health categorization and compound handling practice systems—roots, application and future

  title={Occupational health categorization and compound handling practice systems—roots, application and future},
  author={Allan W. Ader and John Paul Farris and Robert H. Ku},
  journal={Chemical Health and Safety},

History, implementation and evolution of the pharmaceutical hazard categorization and control system

Chemical categorization (or banding) of inherent toxicity and potency linked with defined safe work environments including exposure controls has become an integral component of assuring the health

Occupational Safety and Health

This chapter focuses on exposure via inhalation and skin contact.

The Global Landscape of Occupational Exposure Limits—Implementation of Harmonization Principles to Guide Limit Selection

The underlying reasons for variability in OELs are explored, the harmonization of risk-based methods used by OEL-deriving organizations are recommended, and a framework is proposed for the identification and systematic evaluation of OEL resources.

Developing Acceptable Surface Limits for Occupational Exposure to Pharmaceutical Substances

In the pharmaceuticals industry, ASLs are used for protection against active pharmaceutical ingredients that are known to cause pharmacological or toxicological effects and to protect individuals who might come in direct contact with contaminated surfaces in the workplace.

Important elements in evaluating contract manufacturing organizations : in the handling of potent active pharmaceutical ingredients and products

It is a universal truth that research, development manufacture and formulation of potent active pharmaceutical ingredients (APIs) and products requires both "hardware" (facilities, equipment and

Development of risk-based nanomaterial groups for occupational exposure control

The development of science-based hazard and risk categories for nanomaterials is needed for decision-making about exposure control practices in the workplace and utilizing data and information from related materials may facilitate initial determinations of exposure control systems for nanmaterials.

Chemical Use in Animal Models

A general approach to the engineering, administrative, and personal protective equipment practices for developing an animal chemical control banding system is described.

Inhalable Dust Measurements as a First Approach to Assessing Occupational Exposure in the Pharmaceutical Industry

Though restricted to dust exposure, the study highlighted some potentially critical situations or operations, in particular manual tasks (loading, unloading, mechanical actions) performed in open systems, which should reduce dust emissions and workers’ exposure to inhalable dust.

Considerations for setting occupational exposure limits for novel pharmaceutical modalities

Handling of Highly Potent Pharmaceutical Compounds Effective strategies for Contract Manufacturing Organizations

An example of a control banding method for pharmaceuticals that is used to categorize employee hazard is presented and a summary of the key components of an effective potent compound containment strategy is discussed.



Performance-based exposure control limits for pharmaceutical active ingredients.

The trend in the pharmaceutical industry is to identify and develop more selective drugs of increasing potency, and because of the difficulty in identifying no-effect levels for certain drugs, a new performance-based approach for setting limits was developed.

Containment in the Pharmaceutical Industry

Why containment? Then and now containment and good manufacturing practices industrial hygiene aspects of pharmaceutical manufacturing effect of individual particle characteristics on airborne

Biosafety in microbiological and biomedical laboratories

African horse sickness (AHSV) 246, 350, 353-55, 373, 401 African swine fever virus (ASFV) 246, 350, 352, 373, 401 Agriculture Agents 343, 352 Agriculture pathogen biosafety 343 Akabane virus 350,

and Safety Executive ‘‘Control of Substances Hazardous to Health Essentials’’, HSE 1999, 2000

  • 2003. COSHH Essentials, 2003 (url: http:// www.coshh-essentials.org.uk/assets/ live/CETB.pdf). Accessed January
  • 2005